Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 109 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1081 10.9 months Metastatic melanoma 4 Chemotherapy
Mayo Clinic United States 4/2011
Treatment Details: Patients: This phase 2 study involved metastatic melanoma patients who were divided into two separate groups. Group A had 34 previously treated patients with a median age of 60 years and 6
 
1082 10.9 months Advanced NSCLC 5 Biologic therapy
VU University Medical Center Amsterdam Netherlands 6/2010
Treatment Details: Patients: This study involved 50 patients with advanced non-small cell lung cancer who had not received previous chemotherapy. The median patient age was 60 years and 56% were male. Tre
 
1083 10.9 months Malignant pleural mesothelioma 5 Chemotherapy
Humanitas Clinical Institute of Rozzano Italy 4/2008
Treatment Details: Patients: This study involved 30 malignant pleural mesothelioma patients, 73% of whom were male. The median patient age was 66 years. Treatment: Patients were treated with the chemothe
 
1084 10.9 months Malignant pleural mesothelioma 5 Chemotherapy
Humanitas Clinical Institute of Rozzano Italy 4/2008
Treatment Details: Patients: This study involved 30 malignant pleural mesothelioma patients with a median age of 66 years (range of 46-85). Of these, 73% were male. Treatment: Patients in this study were
 
1085 10.9 months Metastatic renal cell carcinoma 5 Biologic therapy
Chemotherapy
Immunotherapy
Alegent Bergan Mercy Medical Center United States 4/2002
Treatment Details: Patients: This Phase II trial involved 58 patients with metastatic renal cell carcinoma; 41 men and 17 women. Median age was 57 years. Prior treatments included nephrectomy (44 patients),
 
1086 10.9 months Newly diagnosed GBM 4 Chemotherapy
Radiation
University of Wisconsin Medical School United States 7/2004
Treatment Details: Patients: This Phase I study involved 26 patients with glioblastoma multiforme and 5 patients with anaplastic astrocytoma. Treatment: Treatment consisted of iododeoxyuridine (a potentia
 
1087 10.8 months Advanced NSCLC 4 Chemotherapy
Tochigi Cancer Center Japan 5/2005
Treatment Details: Patients: This Phase II study involved 43 patients with advanced non-small-cell lung cancer. Twenty-nine were men, and fourteen were women. The median age was 61 years. Thirty-five had st
 
1088 10.8 months Hormone-refractory prostate cancer 4 Chemotherapy
University of Southern California United States 11/2005
Treatment Details: Patients: This Phase II study involves 29 men with advanced metastatic hormone refractory prostate cancer. The median age was 73 years. Metastatic sites include bone, lymph node, liver, an
 
1089 10.8 months Metastatic colorectal cancer 5 Biologic therapy
Chemotherapy
Aichi Cancer Center Hospital Japan 12/2010
Treatment Details: Patients: This phase II study involved 30 metastatic colorectal cancer patients (mCRC) who were resistant to previous irinotecan, oxaliplatin, and fluoropyrimidine treatment. The median pa
 
1090 10.8 months Hepatocellular carcinoma 5 Biologic therapy
Chemotherapy
Johns Hopkins School of Medicine United States 11/2012
Treatment Details: Patients: This phase 2 study involved 26 hepatocellular carcinoma patients, 21 of whom were males. The median patient age was 64 years. Treatment: Patients were treated with the biolog
 
Page 109 of 187  | Previous Page  | Next Page